These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 18707553

  • 1. Effects of the 7-valent pneumococcal conjugate vaccine on U.S. levofloxacin-resistant Streptococcus pneumoniae.
    Davies TA, Yee YC, Bush K, Sahm D, Evangelista A, Goldschmidt R.
    Microb Drug Resist; 2008 Sep; 14(3):187-96. PubMed ID: 18707553
    [Abstract] [Full Text] [Related]

  • 2. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ, Klugman KP, Pichichero M.
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [Abstract] [Full Text] [Related]

  • 3. Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine.
    Pletz MW, McGee L, Jorgensen J, Beall B, Facklam RR, Whitney CG, Klugman KP.
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3491-7. PubMed ID: 15328116
    [Abstract] [Full Text] [Related]

  • 4. Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine.
    Mera R, Miller LA, Fritsche TR, Jones RN.
    Microb Drug Resist; 2008 Jun; 14(2):101-7. PubMed ID: 18491947
    [Abstract] [Full Text] [Related]

  • 5. Fluoroquinolone-nonsusceptible Streptococcus pneumoniae isolates from a medical center in the pneumococcal conjugate vaccine era.
    Chen HH, Li HC, Su LH, Chiu CH.
    J Microbiol Immunol Infect; 2017 Dec; 50(6):839-845. PubMed ID: 27342636
    [Abstract] [Full Text] [Related]

  • 6. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH.
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [Abstract] [Full Text] [Related]

  • 7. Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan.
    Hsieh YC, Chang LY, Huang YC, Lin HC, Huang LM, Hsueh PR.
    Clin Microbiol Infect; 2010 Jul; 16(7):973-8. PubMed ID: 19778298
    [Abstract] [Full Text] [Related]

  • 8. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Dagan R.
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
    [Abstract] [Full Text] [Related]

  • 9. Novel Ser79Leu and Ser81Ile substitutions in the quinolone resistance-determining regions of ParC topoisomerase IV and GyrA DNA gyrase subunits from recent fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
    Korzheva N, Davies TA, Goldschmidt R.
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2479-86. PubMed ID: 15917550
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamics of levofloxacin against characterized ciprofloxacin-resistant Streptococcus pneumoniae.
    Lister PD.
    Postgrad Med; 2008 Sep; 120(3 Suppl 1):46-52. PubMed ID: 18931471
    [Abstract] [Full Text] [Related]

  • 11. High prevalence of multiresistance in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea.
    Lee S, Kim SH, Park M, Bae S.
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):227-31. PubMed ID: 23623384
    [Abstract] [Full Text] [Related]

  • 12. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.
    Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Rice CL, Doern GV.
    Clin Infect Dis; 2005 Jan 15; 40(2):225-35. PubMed ID: 15655739
    [Abstract] [Full Text] [Related]

  • 13. Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee.
    Halasa NB, Grijalva CG, Arbogast PG, Talbot TR, Craig AS, Griffin MR, Schaffner W.
    Pediatr Infect Dis J; 2013 Jun 15; 32(6):604-9. PubMed ID: 23348816
    [Abstract] [Full Text] [Related]

  • 14. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.
    Huang SS, Platt R, Rifas-Shiman SL, Pelton SI, Goldmann D, Finkelstein JA.
    Pediatrics; 2005 Sep 15; 116(3):e408-13. PubMed ID: 16140686
    [Abstract] [Full Text] [Related]

  • 15. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.
    Jacobs MR, Good CE, Bajaksouzian S, Windau AR.
    Clin Infect Dis; 2008 Dec 01; 47(11):1388-95. PubMed ID: 18959493
    [Abstract] [Full Text] [Related]

  • 16. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
    Parra EL, De La Hoz F, Díaz PL, Sanabria O, Realpe ME, Moreno J.
    Vaccine; 2013 Aug 20; 31(37):4033-8. PubMed ID: 23680440
    [Abstract] [Full Text] [Related]

  • 17. Molecular epidemiology of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae in Seville.
    Iraurgui P, Torres MJ, Aznar J.
    Enferm Infecc Microbiol Clin; 2012 Apr 20; 30(4):180-3. PubMed ID: 22365183
    [Abstract] [Full Text] [Related]

  • 18. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.
    Kaplan SL, Mason EO, Wald ER, Schutze GE, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Yogev R, Barson WJ.
    Pediatrics; 2004 Mar 20; 113(3 Pt 1):443-9. PubMed ID: 14993532
    [Abstract] [Full Text] [Related]

  • 19. Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates.
    Pelton SI, Loughlin AM, Marchant CD.
    Pediatr Infect Dis J; 2004 Nov 20; 23(11):1015-22. PubMed ID: 15545856
    [Abstract] [Full Text] [Related]

  • 20. Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003).
    Davies TA, Yee YC, Goldschmidt R, Bush K, Sahm DF, Evangelista A.
    J Antimicrob Chemother; 2006 Mar 20; 57(3):437-42. PubMed ID: 16431861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.